Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The coronary atherectomy devices market has seen notable growth recently, driven by advances in cardiovascular care and increasing demand for minimally invasive treatments. As more people worldwide face heart-related health challenges, this market is poised for substantial expansion. Let’s explore the current market size, the factors fueling its growth, segmentation, innovation trends, key players, and regional dynamics shaping the industry’s future.

Market Size and Growth Trajectory of the Coronary Atherectomy Devices Market

The coronary atherectomy devices market has experienced rapid development in recent years. It is projected to increase from $0.23 billion in 2025 to $0.26 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.1%. This historical growth mainly stems from the rising incidence of coronary artery disease, the growing adoption of interventional cardiology procedures, expansion of catheterization labs, an aging population, and clinical validation of atherectomy techniques. Looking ahead, the market is expected to expand further, reaching $0.37 billion by 2030 with a CAGR of 9.4%. Key factors driving this future growth include a surge in demand for complex coronary interventions, wider use of image-guided cardiovascular procedures, increased investments in cardiac care infrastructure, technological improvements enhancing device precision, and broader implementation of minimally invasive treatment methods. Important trends forecasted during this period include expanded use of advanced rotational atherectomy devices, growing preference for minimally invasive coronary procedures, heightened focus on treating calcified lesions, deployment of precision-controlled atherectomy systems, and improved integration with imaging-guided interventions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3345&type=smp

The Rising Burden of Cardiovascular Diseases Boosting Coronary Atherectomy Devices Market

One major driver behind the coronary atherectomy devices market is the increasing prevalence of cardiovascular diseases (CVDs), which encompass a range of disorders affecting the heart and blood vessels. These conditions are often linked to plaque accumulation, restricted blood flow, and gradual narrowing of arteries. The escalation in cardiovascular disease cases is closely tied to widespread modifiable risk factors such as high blood pressure, obesity, diabetes, unhealthy diets, sedentary lifestyles, and tobacco use. This growing health challenge heightens the need for minimally invasive tools like coronary atherectomy devices that effectively remove calcified or complex plaques, restore blood flow, and improve outcomes during percutaneous coronary interventions (PCI). For instance, data released in October 2024 by the US Centers for Disease Control and Prevention revealed that in 2023, about one in six cardiovascular disease deaths occurred in adults younger than 65, and overall, cardiovascular disease caused 919,032 deaths—representing one in every three deaths nationally. Such statistics highlight how the rising cardiovascular disease burden is significantly propelling global demand for coronary atherectomy devices.

Segmentation and Revenue Streams in the Coronary Atherectomy Devices Market

This market is segmented based on product types, applications, and end users to illustrate its broad scope. The product categories include Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, and other related products. Applications span Peripheral Vascular, Cardiovascular, and Coronary Artery Disease treatments. End users primarily consist of Hospitals and Surgical Centers, Ambulatory Care Centers, and Cardiac Specialty Centers. Further subdivisions provide more detail, such as Traditional and Advanced Directional Atherectomy Devices; Single-Wire and Multi-Wire Orbital Atherectomy Devices; Laser-Based and Other Photo-Ablative Devices; Manual and Motorized Rotational Atherectomy Devices; and additional specialized products like Combination Atherectomy Devices and Custom Solutions. This segmentation reflects the diverse technologies and clinical needs driving the market.

Access The Complete Coronary Atherectomy Devices Market Report:

https://www.thebusinessresearchcompany.com/report/coronary-atherectomy-devices-global-market-report

Innovations and Technology Shaping the Future of Coronary Atherectomy Devices

Leading companies in the coronary atherectomy market are emphasizing innovation to enhance patient care and procedural safety. One notable advancement is the development of radial access catheters, which enable less invasive coronary artery treatments by accessing arteries via the wrist instead of the groin. This approach reduces major bleeding risks and promotes faster patient recovery. For example, in January 2024, AngioDynamics, a US healthcare solutions provider, received FDA 510(k) clearance for its Auryon XL Radial Access Catheter. This 225-cm device, compatible with the Auryon Atherectomy System, offers two diameter sizes and leverages advanced laser technology to treat peripheral arterial disease effectively. Radial access catheters also facilitate treatment of bilateral disease in a single session, supporting improved clinical outcomes and patient convenience.

Key Market Players Driving Competition in Coronary Atherectomy Devices

The coronary atherectomy devices market is highly competitive, with several prominent companies leading the field. Major players include Boston Scientific Corporation, Cardiovascular Systems Inc., The Spectranetics Corporation, Medtronic Inc., Avinger Inc., Biotronik SE & Co. KG, Arterial Remodeling Technologies, Straub Medical AG, RA Medical Systems Inc., Shockwave Medical Inc., Terumo Corporation, Abbott Laboratories Inc., Asahi Intecc Co. Ltd., Baylis Medical Company Inc., Cook Medical LLC, Cordis Corporation, Infraredx Inc., Intact Vascular Inc., TriReme Medical LLC, and Volcano Corporation. These organizations focus on technological advancements, expanding product portfolios, and strategic collaborations to retain leadership and meet evolving clinical demands.

Geographic Distribution and Regional Market Dynamics of Coronary Atherectomy Devices

Geographically, North America held the largest share of the coronary atherectomy devices market in 2025, reflecting the region’s advanced healthcare infrastructure and high adoption of interventional cardiology procedures. Western Europe ranked as the second-largest market, benefiting from well-established medical device regulations and strong healthcare systems. Meanwhile, Africa remained the smallest regional market due to limited healthcare access and lower adoption rates. The market analysis also includes other important regions such as Asia-Pacific, South East Asia, Eastern Europe, South America, and the Middle East, providing a global perspective on growth opportunities and market challenges.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model